Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Department of Labor delivered a one-two punch for American workers this past week, announcing the recovery of more than $259 million in stolen wages for …
Labor’s $259M Payday and a Maritime Rebuild Ignite Trump’s Worker Push Read More
PENNSYLVANIA — Frequent drivers on the Pennsylvania Turnpike are starting 2026 with higher tolls, as the Pennsylvania Turnpike Commission has approved another increase in rates. The hike marks the 18th …
Pennsylvania Turnpike Tolls Rise in 2026, Though Increase Is Smallest in Over a Decade Read More
WASHINGTON, D.C. — The U.S. Department of Labor announced a $98 million funding initiative designed to expand pre-apprenticeship programs and steer young Americans into high-demand industries as the Trump administration …
$98M Federal Push Aims to Fast-Track Youth Into High-Demand Careers Read More
WASHINGTON, D.C. — The Federal Housing Administration helped more than 876,000 Americans secure a path to homeownership in fiscal year 2025 while building one of the strongest financial buffers in …
FHA Report Shows Massive Cushion as Agency Backs 876,000 New Homebuyers Read More
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) said the U.S. Food and Drug Administration has accepted its Biologics License Application for INO-3107, a potential non-surgical treatment for adults with recurrent …
FDA Sets 2026 Decision Clock for INOVIO’s Rare Disease Therapy Read More
WILMINGTON, DE — AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo (TYO: 4568) said their jointly developed breast cancer therapy ENHERTU has received Breakthrough Therapy Designation from the U.S. Food and Drug …
ENHERTU Scores Tenth FDA Fast-Track as Breast Cancer Data Shifts Playbook Read More
PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) said the U.S. Food and Drug Administration has approved Exdensur, a twice-yearly biologic treatment for patients with severe asthma characterized by an eosinophilic …
FDA Clears GSK’s Twice-Yearly Asthma Drug, Signaling Shift in Biologic Care Read More WILMINGTON, DE — AstraZeneca PLC (NASDAQ: AZN) and Japan’s Daiichi Sankyo said the U.S. Food and Drug Administration has approved ENHERTU in combination with pertuzumab as a first-line treatment for …
FDA Clears ENHERTU Combo as First-Line Breakthrough in HER2 Breast Cancer Read More
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the first and only subcutaneous therapy for patients with EGFR-mutated non-small …
FDA Clears Five-Minute Lung Cancer Shot, Redefining EGFR Treatment Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) said the U.S. Food and Drug Administration has granted Fast Track designation to QTORIN™ rapamycin for the treatment of angiokeratomas, a rare …
FDA Fast Track Puts Palvella’s Rare Skin Drug on a Faster Regulatory Path Read More